Cancer Research Discovery Announced by Two Biotechnology Companies

March 10, 2015

Two innovative medical technology companies, InSilico Medicine, Inc. and Champions Oncolology, Inc., have discovered what may prove to be a “green light” tool in colon cancer treatment; a tool that helps doctors choose the most promising path to treat a patient when so many other treatment options are available. The discovery may lead to more effective treatment of colon cancer.



Qnostics is a manufacturer of a variety of own-label and custom manufactured molecular controls.


Simplifying gene transfer with SpinOculation C-Pro application software

video | August 23, 2021

SpinOculation C-Pro application software is designed to support the gene transfer step of your CAR-T cell manufacturing process. See how you can preserve cell viability and virus stability with convenient, closed, and automated gene transfer....

Watch Now

Moleculin Biotech, Inc MBRX Stock Chart Technical Analysis for 04-16-2020

video | April 16, 2020 and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. Investing/trading in securities is highly speculative and carries an extremely high degree of risk....

Watch Now

Biotech Innovations: Virus & DNA Analysis; Antibody Probiotics

video | April 13, 2020

A sneak peak into some of the latest, cutting-edge life science innovations on Virus analysis; Antibody; Probiotics; & DNA Analysis. It was prepared in cooperation with Massouh bioMÉDia for a Canadian association that brings together life science industry leaders....

Watch Now

Accelerating Emerging Biotech: Collaborating on biomanufacturing capacity

video | April 12, 2020

Emerging therapies require flexibility ‒ to manufacture smaller batches at the beginning and much bigger batches when needed, all within the right GMP environment. Flexible capacity is critical to minimize risk, maximize speed, and avoid unnecessary delays in regulatory support and approval....

Watch Now